These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 1611641)

  • 1. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
    Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
    Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
    Hyslop DL; Jacobson K; Guerra FJ
    Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion.
    Foshee WS
    J Pediatr; 1992 Jun; 120(6):980-6. PubMed ID: 1593361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis.
    Dubois J; Saint-Pierre C; Tremblay C
    Ear Nose Throat J; 1993 Dec; 72(12):804-10. PubMed ID: 8313865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
    Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
    Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid.
    Brook I; Foote PA; Hausfeld JN
    Int J Antimicrob Agents; 2005 Nov; 26(5):416-9. PubMed ID: 16226017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
    Tassler H
    Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children.
    Gehanno P; Berche P; Boucot I; Lambert-Zechovsky N; Bingen E; Gres JJ; Rollin C
    J Antimicrob Chemother; 1994 Jun; 33(6):1209-18. PubMed ID: 7928814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
    Zeckel ML
    Am J Med; 1992 Jun; 92(6A):58S-64S. PubMed ID: 1621746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae.
    Patel JA; Reisner B; Vizirinia N; Owen M; Chonmaitree T; Howie V
    J Pediatr; 1995 May; 126(5 Pt 1):799-806. PubMed ID: 7752010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
    Khajotia RR; Vetter N; Harazin H
    Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open trial of oral fleroxacin versus amoxicillin/clavulanate in the treatment of infections of skin and soft tissue.
    Powers RD
    Am J Med; 1993 Mar; 94(3A):155S-158S. PubMed ID: 8452173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.
    Gan VN; Kusmiesz H; Shelton S; Nelson JD
    Antimicrob Agents Chemother; 1991 May; 35(5):967-71. PubMed ID: 1854178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of a five-day regimen of cefdinir with a seven-day regimen of loracarbef for the treatment of acute exacerbations of chronic bronchitis.
    Paster RZ; McAdoo MA; Keyserling CH; Nemeth MA; Tack KJ; Griffin TJ
    Int J Clin Pract; 2000 Jun; 54(5):293-9. PubMed ID: 10954955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of loracarbef in the treatment of pneumonia.
    Hyslop DL
    Am J Med; 1992 Jun; 92(6A):65S-69S. PubMed ID: 1621747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.